Gregory Mattingly, MD, president, Midwest Research Group, founding partner, St. Charles Psychiatric Associates, discusses the ...

The Cambridge, Mass., biotechnology company on Thursday said it received a notice of allowance from the U.S. Patent and Trademark Office regarding the drug candidate, ED-003, which is intended to ...

The potential legalization of magic mushrooms is heading to Olympia next week as state lawmakers prepare to hear testimony on ...

If approved, the 2025 proposals would allow for a two-year development phase before the state starts handing out licenses in ...

Canaccord Genuity analysts downgraded Intra-Cellular Therapies (NASDAQ:ITCI) stock from Buy to Hold, adjusting the price target to $132 from the previous $119. The revision follows the recent ...

Psilocybin significantly reduces confidence in negative self-beliefs four weeks after administration, with effects linked to ...

Legislation to create a program for the medicinal use of psilocybin was introduced today in the New Mexico Senate. Senate Bill 219, the Medical Psilocybin Act, would allow those in New Mexico to ...

A group of lawmakers introduced a proposal Thursday to establish a program for medicinal use of psilocybin mushrooms.

Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company dedicated to the development of ...

In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on study results, an analyst ...

Research analysts at HC Wainwright issued their FY2029 earnings per share (EPS) estimates for shares of GH Research in a report released on Monday, January 27th. HC Wainwright analyst P. Trucchio ...